<DOC>
	<DOCNO>NCT00495196</DOCNO>
	<brief_summary>The purpose trial investigate cardiovascular response peripheral chemoreceptor stimulation Congestive Heart Failure Cheyne- Stokes Respiration</brief_summary>
	<brief_title>Cardiovascular Responses Congestive Heart Failure With Cheyne- Stokes Respiration</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Cheyne-Stokes Respiration</mesh_term>
	<criteria>Moderate severe heart failure ( NYHA Class II ) optimal medical therapy LVEF le equal 45 % Stable condition define hospital admission change medical therapy within two week prior enrolment Patients take known respiratory stimulant depressant Clinically significant asthma require therapy Significant parenchymal lung disease Primary pulmonary hypertension Myocardial infarction within three month prior enrolment Patients cardiac resynchronisation device permanent pacemaker Anaemic ( haemoglobin &lt; 12g/dL )</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2010</verification_date>
</DOC>